Search Results - "De Cos, María Angeles"

  • Showing 1 - 16 results of 16
Refine Results
  1. 1
  2. 2

    Within-Patient Variability in Tacrolimus Blood Levels Predicts Kidney Graft Loss and Donor-Specific Antibody Development by Rodrigo, Emilio, Segundo, David San, Fernández-Fresnedo, Gema, López-Hoyos, Marcos, Benito, Adalberto, Ruiz, Juan Carlos, de Cos, Maria-Angeles, Arias, Manuel

    Published in Transplantation (01-11-2016)
    “…BACKGROUNDLack of adherence to immunosuppressive drugs is a risk factor for development of de novo donor-specific antibodies (dnDSA) and can contribute to…”
    Get full text
    Journal Article
  3. 3

    Calcineurin inhibitors’ impact on cardiovascular and renal function, a descriptive study in lung transplant recipients from the North of Spain by Nogueiras-Álvarez, Rita, Mora-Cuesta, Víctor Manuel, Cifrián-Martínez, José Manuel, de Cos-Cossío, María Ángeles, García-Sáiz, María del Mar

    Published in Scientific reports (08-12-2022)
    “…Patients undergoing lung transplantation (LTx) need administration of immunosuppressive therapy following the procedure to prevent graft rejection. However,…”
    Get full text
    Journal Article
  4. 4

    Lower Time in Therapeutic Range Relates to a Worse Kidney Graft Outcome by Barreda, Paloma, Cañamero, Lucía, Boya, Marta, García-Saiz, María Del Mar, Valero, Rosalía, Belmar, Lara, Kislikova, María, De Cos, María Angeles, Ruiz, Juan Carlos, Rodrigo, Emilio

    Published in Transplantation proceedings (01-11-2022)
    “…•Individual tacrolimus blood levels are the usual way to monitor the immunosuppressive effect in solid organ transplant.•A greater variability throughout a…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

    A Retrospective Review of Calcineurin Inhibitors’ Impact on Cytomegalovirus Infections in Lung Transplant Recipients by Nogueiras-Álvarez, Rita, Mora-Cuesta, Víctor, Cifrián Martínez, José, de Cos Cossío, María, García Sáiz, María

    Published in Transplantology (Basel, Switzerland) (01-12-2021)
    “…Immunosuppressive therapy reduces the risk for allograft rejection but leaves recipients susceptible to infections. Cytomegalovirus (CMV) is one of the most…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Time course of trough serum gentamicin concentrations in preterm and term neonates by DE COS, M. A, GOMEZ-ULLATE, J, GOMEZ, F, ARMIJO, J. A

    Published in Clinical pharmacokinetics (01-11-1992)
    “…Trough serum concentrations (Cmin) of gentamicin were followed during up to 96h of treatment in 44 neonates (17 preterm and 27 term), treated with…”
    Get full text
    Journal Article
  12. 12

    A survey of postoperative pain treatment in children of 3–14 years by Baños, Josep-Eladi, Barajas, Conchita, Martin, Maria Luisa, Hansen, Elisabet, de Cos, Maria Angeles, Bosch, Félix, Martin, Rafael, Marco, Joan, Dierssen, Trinidad

    Published in European journal of pain (01-09-1999)
    “…There is a lack of information concerning the characteristics of pediatric postoperative pain in Southern European countries. The aim of this study was to…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    Modulation of autoantibody production by mycophenolate mofetil: effects on the development of SLE in (NZB×NZW)F1 mice by Ramos, Ma Angeles, Piñera, Celestino, Setién, Ma Angeles, Buelta, Luis, de Cos, Ma Angeles, de Francisco, Angel‐Luis M., Merino, Ramón, Arias, Manuel

    Published in Nephrology, dialysis, transplantation (01-05-2003)
    “…Background. Mycophenolate mofetil (MMF) has been successfully used to improve or prevent the development of systemic lupus erythematosus (SLE) in both humans…”
    Get full text
    Journal Article
  16. 16